45 Results for "

adaptor

" in MedChemExpress (MCE) Product Catalog:
Products (45)

45 Results for "adaptor" in MCE Product Catalog:

  • Targets Recommended:
11
11 Publications Verification
Cat. No.: HY-144226
CAS No.: 1787787-60-3
Purity:  98.23%
NLRP3/AIM2-IN-3 (compound 59) is a potent inhibitor with differential species specific effects against NLRP3 and AIM2 inflammasome-dependent pyroptosis. NLRP3/AIM2-IN-3 shows inhibitory efficacy against pyroptosis in THP-1 macrophages stimulated with LPS/nigericin, with an IC50 of 0.077 ± 0.008 μM. NLRP3/AIM2-IN-3 disturbs the interaction of NLRP3 or AIM2 with the adaptor protein ASC and inhibited ASC oligomerization .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-138646
CAS No.: 86828-69-5
Synonyms: Poly(dA:dT) sodium
Research Areas:  

Inflammation/Immunology

Poly(deoxyadenylic-thymidylic) acid (Poly(dA:dT)) sodium is a double-stranded DNA stimulant. Poly(deoxyadenylic-thymidylic) acid sodium is recognized by the intracellular DNA sensor DDX41 and activates the innate immune pathway via the adaptor protein STING, inducing the production of cytokines such as type I interferons. Poly(deoxyadenylic-thymidylic) acid sodium also serves as an in vitro transcription template for free RNA polymerase .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-117626
CAS No.: 1454555-29-3
Purity:  99.74%
LP-935509 is an orally active, potent, selective, ATP-competitive and brain-penetrant inhibitor of adaptor protein-2 associated kinase 1 (AAK1) with an IC50 of 3.3 nM and a Ki of 0.9 nM, respectively. LP-935509 is also a potent inhibitor of BIKE (IC50=14 nM) and a modest inhibitor of GAK (IC50=320 nM). LP-935509 shows antinociceptive activity. LP-935509 can be used for neuropathic pain and SARS-CoV-2 research .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-134829
CAS No.: 1815613-42-3
Purity:  98.79%
Synonyms: LX-9211; AAK1-IN-1
Target:  

AAK1

Research Areas:  

Neurological Disease

BMS-986176 (LX-9211) is a highly selective, brain-penetrant, potent AAK1 (adaptor associated kinase 1) inhibitor with an IC50 of 2 nM. BMS-986176 can be used for neurodegenerative diseases research .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-14604
CAS No.: 90494-79-4
Purity:  98.57%
Synonyms: SR57746A; SR57746 hydrochloride
Xaliproden (SR57746) hydrochloride (SR57746A) is an orally active, highly selective 5-HT1A receptor agonist. Xaliproden hydrochloride activates pertussis toxin-sensitive G protein-coupled signaling cascades, as well as the PKC, ERK1/ERK2, Akt and p21 Ras/MEK-1 pathways. Xaliproden hydrochloride also downregulates the JNK/p66/c-Jun signaling pathway, induces phosphorylation of the shc adaptor protein, regulates extracellular dopamine and 5-HT levels, and induces [ 35S]GTPγS labeling in rat brain structures rich in 5-HT1A receptors. Xaliproden hydrochloride exerts neurotrophic, neuroprotective, renoprotective, anti-inflammatory, anti-apoptotic, anti-fibrotic and analgesic effects. Xaliproden hydrochloride also enhances NGF-induced neurite outgrowth, promotes motor neuron survival, attenuates renal tubular injury and inhibits chemotherapy-induced mechanical allodynia, without activating or altering NGF-induced TrkA receptor activation. Xaliproden hydrochloride can be used in the research of motor neuron disease, diabetic nephropathy, chemotherapy-induced peripheral neuropathy, amyotrophic lateral sclerosis, Alzheimer's disease, acute tonic nociceptive pain, inflammatory pain, depression and anxiety .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-132309
CAS No.: 2760881-74-9
Purity:  98.04%
Research Areas:  

Cancer

BRD0639 is a first-in-class inhibitor of the PRMT5-substrate adaptor interaction. BRD0639 is a PRMT5 binding motif (PBM)-competitive agent that can support studies of PBM dependent PRMT5 activities .
loading...
    loading...
Cat. No.: HY-115868
CAS No.: 1644248-18-9
Purity:  99.49%
Target:  

AAK1

Research Areas:  

Neurological Disease

BMS-911172 is an adaptor associated kinase 1 (AAK1 kinase) inhibitor (IC50 = 35 nM).
loading...
    loading...
Cat. No.: HY-161166
Target:  

Others

Research Areas:  

Others

MM-02-57 is a covalent DDB1 CUL4A adaptor protein recruiter .
loading...
    loading...
Cat. No.: HY-175536
Target:  

AAK1

Research Areas:  

Infection

AAK1-IN-11 is an AAK1 (adaptor associated kinase 1) inhibitor with an IC50 of 2 nM. AAK1-IN-11 has antiviral activity .
loading...
    loading...
Cat. No.: HY-174312
CAS No.: 2922814-85-3
NLRP3-IN-81 (N102) is a BBB-penetrable inhibitor against NLRP3 inflammasome-dependent pyroptosis with an EC50 of 0.029 μM against cell pyroptosis induced by Nigericin (HY-127019). NLRP3-IN-81 potently inhibits NLRP3-dependent activation of caspase-1 and the release of IL-1β. NLRP3-IN-81 disturbs the interaction of NLRP3 with the adaptor protein ASC and inhibits ASC oligomerization. NLRP3-IN-81 can be used for pyroptosis-related diseases research, such as inflammatory bowel diseases and type 2 diabetes .
loading...
    loading...
Cat. No.: HY-144301
CAS No.: 1802703-21-4
Target:  

AAK1

Research Areas:  

Neurological Disease

AAK1-IN-2 (compound (S)-31) is a potent, selective and brain-penetrant inhibitor of Adaptor Protein 2-Associated Kinase 1 (AAK1), with an IC50 of 5.8 nM. AAK1-IN-2 can be used for the research of neuropathic pain .
loading...
    loading...
Cat. No.: HY-144301A
CAS No.: 2761587-28-2
Target:  

AAK1

Research Areas:  

Neurological Disease

AAK1-IN-2 TFA (compound (S)-31) is a potent, selective and brain-penetrant inhibitor of Adaptor Protein 2-Associated Kinase 1 (AAK1), with an IC50 of 5.8 nM. AAK1-IN-2 TFA can be used for the research of neuropathic pain .
loading...
    loading...
Cat. No.: HY-144302
CAS No.: 1802703-20-3
Target:  

AAK1

Research Areas:  

Neurological Disease

AAK1-IN-3, a quinoline analogue, is a brain-penetrant adaptor protein 2-associated kinase 1 (AAK1) inhibitor with an IC50 of 11 nM. AAK1-IN-3 has the potential for neuropathic pain research .
loading...
    loading...
Cat. No.: HY-144302A
CAS No.: 2761587-27-1
Target:  

AAK1

Research Areas:  

Neurological Disease

AAK1-IN-3 TFA, a quinoline analogue, is a brain-penetrant adaptor protein 2-associated kinase 1 (AAK1) inhibitor with an IC50 of 11 nM. AAK1-IN-3 has the potential for neuropathic pain research .
loading...
    loading...
Cat. No.: HY-169578
CAS No.: 904458-98-6
Target:  

PKC

Research Areas:  

Cancer

PKC-IN-5 (Compound PKCe2054) is a PKC inhibitor. PKC-IN-5 prevents the interaction between PKCe and its adaptor protein RACK2 .
loading...
    loading...
Cat. No.: HY-120092
CAS No.: 1551401-20-7
Target:  

AAK1

Research Areas:  

Neurological Disease

BMT-046091 is a selective inhibitor of adaptor-associated kinase 1 (AAK1). BMT-046091 inhibits phosphorylation of the μ2 peptide by AAK1 with an IC50 value of 2.8 nM .
loading...
    loading...
Cat. No.: HY-176705
Target:  

AAK1

Research Areas:  

Neurological Disease

AAK1-IN-9 (Compound 3) is an AAK1 (adaptor associated kinase 1) inhibitor with an IC50 of 10.92 nM. AAK1-IN-9 can be used in the study of neurodegenerative diseases .
loading...
    loading...
Cat. No.: HY-124996
Purity:  98.96%
(Rac)-ZLc-002, an inhibitor of nNOS interaction with nitric oxide synthase 1 adaptor protein (NOS1AP), suppresses inflammatory nociception and chemotherapy-induced neuropathic pain and synergizes with Paclitaxel (HY-B0015) to reduce tumor cell viability .
loading...
    loading...
Cat. No.: HY-174514
Target:  

mRNA

Research Areas:  

Cancer

Human TNFRSF4 mRNA encodes the human TNF receptor superfamily member 4 (TNFRSF4) protein, a member of the TNF receptor superfamily. TNFRSF4 has been shown to activate NF-kappaB through its interaction with adaptor proteins TRAF2 and TRAF5.
loading...
    loading...
Cat. No.: HY-145838
CAS No.: 1815612-79-3
Target:  

AAK1

Research Areas:  

Neurological Disease

AAK1-IN-4 is a highly selective, CNS-penetrable, and orally active adaptor protein-2-associated kinase 1 (AAK1) inhibitor (AAK1 IC50 of 4.6 nM, Filt Ki of 0.9 nM, and cell IC50 of 8.6 nM). AAK1-IN-4 has the potential for the research for neuropathic pain .
loading...
    loading...